MAM
Mandeep Malhotra promoted to president and head Mudra Max
MUMBAI: Mandeep Malhotra has recently been elevated to president and head Mudra Max and will report to Mudra Group COO Pratap Bose.
Malhotra will be in charge of the Mudra Max’s experiential wing namely Kidstuff, Celsius, Terra and Concrea and retail cluster which includes Prime Retail, Prime Consult, Prime Wayfinding, Multiplier and Pratham. He will also continue with his current role as head of OOH.
Malhotra said, “Mudra Max is a great place to work as it provides a supportive and enabling environment that helps people realize their full potential. I look forward to taking charge of this mandate and leading my team in achieving new highs for our clients.”
Bose said, “Over the last three years Mandeep has done a commendable job in driving the growth and profitability of our OOH businesses and also in creating the finest outdoor team in the country. That apart, his charm, confidence and ‘never say die’ spirit has been extremely endearing and infectious which has always been his biggest asset.”
With a Masters in Business Advertising from Melbourne, Malhotra has over 12 years of professional experience in outdoor media. Prior to this appointment, he has worked with Clear Channel India, Rediffusion DY&R, 141 Wall Street (the OOH arm of Bates 141), Asian Age, Pioneer and Total Media Melbourne. He has managed brands such as Tata Indicom,
Airtel, Reebok, Discovery, CNN IBN and Nokia among others. He has won four One Show awards, three Pencil Awards and a few dozens at the Outdoor Advertising Awards (OAA).
A part of the Gold Lion team at Cannes, he has also received an award for The Entrepreneur of the Year along with bagging The Suit of the Year twice at Ogilvy & RMG. He is the brain behind the recent successful launches of Aircel, Pepsi, Reebok, HT, Jet Airways, Reliance Capital, Micromax and Amway.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
